These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1605631)

  • 61. Measurement of growth hormone and prolactin receptor turnover in rat liver.
    Baxter RC
    Endocrinology; 1985 Aug; 117(2):650-5. PubMed ID: 2990857
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5,5'-Diphenylhydantoin decreases specific 3,5,3'-triiodothyronine (T3) binding by rat hepatic nuclear T3 receptors.
    Mann DN; Surks MI
    Endocrinology; 1983 May; 112(5):1723-31. PubMed ID: 6299706
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic binding of human and bovine growth hormones and ovine prolactin in the dwarf "little" mouse.
    Herington AC; Harrison D; Graystone J
    Endocrinology; 1983 Jun; 112(6):2032-8. PubMed ID: 6303755
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An investigation of sites that bind human somatotropin (growth hormone) in the liver of the pregnant rabbit.
    Cadman HF; Wallis M
    Biochem J; 1981 Sep; 198(3):605-14. PubMed ID: 6275854
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical and immunohistochemical characterization of prolactin binding in rat ventral, lateral, and dorsal prostate lobes.
    Thompson SA; Johnson MP; Brooks CL
    Prostate; 1982; 3(1):45-58. PubMed ID: 6176987
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors.
    Tang SS; Rogg H; Schumacher R; Dzau VJ
    Endocrinology; 1992 Jul; 131(1):374-80. PubMed ID: 1612017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor.
    Barnard R; Bundesen PG; Rylatt DB; Waters MJ
    Biochem J; 1985 Oct; 231(2):459-68. PubMed ID: 2415117
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histone binding to isolated rat liver nuclei.
    Park KS; Kim S; Paik WK
    Int J Biochem; 1987; 19(5):455-9. PubMed ID: 3595992
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modification of arginine residues in ovine prolactin by 1,2-cyclohexanedione. Effect on binding capacity to lactogenic receptors.
    Cymes GD; Atlasovich FM; Caridad JJ; Iglesias MM; Wolfenstein-Todel C
    Int J Pept Protein Res; 1994 Jul; 44(1):31-5. PubMed ID: 7960402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A morphologic analysis of insulin binding sites in isolated rat liver nuclei.
    Sikstrom RA; Posner BI; Bergeron JJ
    Cell Biol Int Rep; 1980 Jan; 4(1):15-22. PubMed ID: 6993017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of the association time of in vivo bound prolactin on the [125I]prolactin receptor assays of female rat livers.
    Brooks CL; Welsch CW
    Mol Cell Endocrinol; 1978; 11(2):145-51. PubMed ID: 210063
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studies on 125I-insulin metabolism by isolated rat liver nuclei.
    Wali RK; Sialy R; Dickson GR; Bansal DD
    Acta Diabetol Lat; 1981; 18(4):365-71. PubMed ID: 7036620
    [No Abstract]   [Full Text] [Related]  

  • 73. Binding of oestradiol, progesterone and prolactin in rat lung.
    Ben-Harari RR; Amit T; Youdim MB
    J Endocrinol; 1983 May; 97(2):301-10. PubMed ID: 6854196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reduced prolactin binding to liver membranes during pheromonal emission in the rat.
    Lee TM; Halpern B; Lee C; Moltz H
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1149-54. PubMed ID: 6298828
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prolactin in liver cytosol and pheromonal emission in the rat.
    Lee TM; Lee C; Moltz H
    Physiol Behav; 1982 Apr; 28(4):631-3. PubMed ID: 7079378
    [No Abstract]   [Full Text] [Related]  

  • 76. Modifications in prolactin binding capacity in the rat liver induced by non-steroidal anti-inflammatory drugs.
    Muccioli G; Bellussi G; Lando D; Di Carlo R
    J Pharm Pharmacol; 1984 Feb; 36(2):95-9. PubMed ID: 6143813
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nonlinear regression analysis of the time course of ligand binding experiments.
    Duggleby RG; Waters MJ
    J Recept Res; 1993; 13(8):1135-46. PubMed ID: 8254579
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction of doxorubicin with nuclei isolated from rat liver and kidney.
    Terasaki T; Iga T; Sugiyama Y; Hanano M
    J Pharm Sci; 1984 Apr; 73(4):524-8. PubMed ID: 6202866
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on the rat liver benzpyrene binding protein.
    Yiannakis PH; Ross H; Brown S
    Biochem Soc Trans; 1991 Apr; 19(2):182S. PubMed ID: 1889566
    [No Abstract]   [Full Text] [Related]  

  • 80. Radioligand receptor assay for prolactin using chicken and turkey kidney membranes.
    Krishnan KA; Proudman JA; Bahr JM
    Comp Biochem Physiol B; 1991; 100(4):769-74. PubMed ID: 1782760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.